Physician

Steven R Partilo, M.D.

According to 2025 Medicare claims, Steven Partilo, M.D. (NPI: 1326016742) practices dermatology in the Burlington-South Burlington, VT market, with the plurality of this provider's patient population coming from Chittenden, VT. This provider's primary affiliated billing organization is GREEN MOUNTAIN DERMATOLOGY PLLC (NPI: 1093577827; TIN: 853348644) and primary practice location at 05446-5988.

Partilo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,296 traditional Medicare patients, billed 4,660 HCPCS/CPT codes, and received $175,551 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 813 prescription claims across 448 beneficiaries totaling $429,600 in drug costs, led by Cosentyx Sensoready (2 Pens) (Secukinumab). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $269,882 to $175,551. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $134,314 to $429,600. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$145K$290K2015 Medicare payment: $269,882 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $255,624 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $289,996 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $271,747 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $252,730 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $215,637 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $235,072 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $178,816 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $171,339 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $175,551 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,5257,569$269,882
20161,5917,071$255,624
20171,7817,655$289,996
20181,7257,101$271,747
20191,7136,550$252,730
20201,4224,995$215,637
20211,5235,795$235,072
20221,1984,484$178,816
20231,2264,257$171,339
20241,2964,660$175,551

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$215K$430K2015 Drug cost: $134,314 (USD; Tot_Drug_Cst)2016 Drug cost: $93,785 (USD; Tot_Drug_Cst)2017 Drug cost: $170,691 (USD; Tot_Drug_Cst)2018 Drug cost: $154,337 (USD; Tot_Drug_Cst)2019 Drug cost: $145,875 (USD; Tot_Drug_Cst)2020 Drug cost: $109,235 (USD; Tot_Drug_Cst)2021 Drug cost: $247,838 (USD; Tot_Drug_Cst)2022 Drug cost: $309,047 (USD; Tot_Drug_Cst)2023 Drug cost: $325,939 (USD; Tot_Drug_Cst)2024 Drug cost: $429,600 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015247566$134,314
2016269501$93,785
2017339677$170,691
2018385726$154,337
2019431797$145,875
2020452813$109,235
2021459834$247,838
2022386702$309,047
2023411801$325,939
2024448813$429,600

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths360400$70
11102Biopsy of related skin growth, first growth212231$59
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,0051,160$54
17000Destruction of precancer skin growth, 1 growth597703$35
17003Destruction of precancer skin growth, 2-14 growths3791,203$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Cosentyx Sensoready (2 Pens)Secukinumab17756$201,651
Dupixent PenDupilumab13350$46,775
FluorouracilFluorouracil1324,026$8,079
Betamethasone DipropionateBetamethasone Dipropionate622,150$4,698
Clobetasol PropionateClobetasol Propionate592,283$2,518

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Steven R. Partilo, M.D.?

Tedicare shows public-source Medicare data for Steven R. Partilo, M.D. (NPI 1326016742), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Steven R. Partilo, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Steven R. Partilo, M.D.?

Steven R. Partilo, M.D. is linked to GREEN MOUNTAIN DERMATOLOGY PLLC (billing NPI 1093577827) in the available physician profile data.

Does Steven R. Partilo, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.